(Q33895933)
Statements
1 reference
Clarification of clinical features of interstitial lung disease induced by irinotecan based on postmarketing surveillance data and spontaneous reports (English)
1 reference
Noritoshi Yoshii
1 reference
Tadamichi Suzuki
1 reference
Masaki Nagashima
1 reference
Akira Kon
1 reference
Koji Kakihata
1 reference
Akihiko Gemma
1 reference
1 July 2011
1 reference
1 reference
22
1 reference
563-568
1 reference